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Abstract 
Background: The incidence of Crohn’s disease (CD) is increasing in Asia and Eastern Europe. 
Limited studies have reported on the frequency of upper gastrointestinal (GI) involvement in 
patients with CD in non-Western countries. This prospective study compared the rate of 
macroscopic and microscopic upper GI manifestations and Helicobacter pylori (H. pylori) 
positivity in asymptomatic CD patients in Asia and Eastern Europe. Methods: Consecutive 
asymptomatic CD patients were prospectively recruited for upper GI endoscopy between 
2013 and 2015 in Hong Kong and in Hungary. Endoscopy and biopsy findings were recorded 
and histology was performed to assess for H. pylori and microscopic signs characteristic for 
CD, using standardized diagnostic criteria. Results: One hundred and eighty CD patients (100 
Hong Kong; 80 Hungary; 70.6% male; mean age, 38.5 years) and 189 controls (100 Hong 
Kong; 89 Hungary; 57.7% male; mean age 41 years) were included. Gastroduodenal 
involvement of CD was significantly higher in Hungary than in Hong Kong (16.5% vs 2.0%, 
p≤0.001). H. pylori positivity was significantly higher in Hungarian than Chinese CD patients 
(13.9% vs. 4.0%, p≤0.001). Granulomas were detected in 1% in Hong Kong and 7.6% in 
Hungary (p≤0.001). Chinese CD subjects had a significantly lower H. pylori positivity 
compared with controls (6% vs. 15%; p≤0.001). Conclusion: Upper GI CD was significantly 
higher in Eastern Europe compared with Asia. The detection of granuloma in Hungary was 
similar to the literature data, whereas focal gastritis was lower than expected in both 
cohorts.  
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Introduction 
The incidence of Crohn’s disease (CD) has been increasing in previously low incidence areas, 
including Asia and Eastern Europe (1-3). Susceptibility genes and disease phenotype may 
differ in CD patients between the East and the West (4). Male predominance and the 
absence of nucleotide-binding oligomerization domain-containing protein 2 (NOD2) / 
caspase recruitment domain-containing protein 15 (CARD15) gene mutation in ileal CD have 
been reported in CD in Asian population (5).  A lower proportion of isolated colonic CD and 
an increased proportion of ileocolonic CD in Asia and Eastern Europe (2, 4) have been 
described when compared with Western European CD patients (6, 7). Observational studies 
have reported a higher proportion of upper GI involvement in Chinese CD patients (8, 9). 
 
Unlike in children with CD whereby upper endoscopy is advocated irrespective of the 
presence or absence of upper GI symptoms (10), in adults with CD, upper GI endoscopy is 
not routinely performed in patients who do not have symptoms. Studies included multiple 
upper GI biopsies on endoscopy have shown that the diagnosis of CD may be missed in 
11-29% of the cases (10). In a Hungarian study of pediatric CD, macroscopic lesions have 
been found on esophagealgastroduodenoscopy (OGD) in 64% of patients with CD. 
Characteristic lesions for CD were noted in 31% of CD patients, and the diagnostic yield of 
OGD proved to be 9% of CD patients (11). 
 
Chow et al. have reported that CD patients with upper GI involvement have worse clinical 
outcomes including increased need of hospitalization and are associated with stricturing and 
penetrating behavior (9). Therefore, there is a need to assess the frequency of upper GI 
involvement among CD as they may represent a distinct or worse phenotype. 
 
This prospective study aimed to compare the prevalence of macroscopic and microscopic 
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upper GI manifestations in asymptomatic CD patients in Asia and Eastern Europe in 
comparison with non-IBD controls. Secondly, we also compared the rates of Helicobacter 
pylori (H. pylori) positivity among CD patients and matched controls. 
 
Patients and methods 
Patient recruitment 
Consecutive asymptomatic CD patients were prospectively recruited for upper GI endoscopy 
between 2013 and 2015 at the Institute of Digestive Disease, the Chinese University of Hong 
Kong, China and at the 1st Department of Medicine, University of Szeged, Hungary. All 
patients from the Hong Kong cohort were ethnically Chinese. The diagnosis of CD was 
confirmed based on strict criteria in both centers. Both hospitals have a dedicated IBD in- 
and outpatient clinic. Only patients with a confirmed diagnosis of CD based on clinical 
evaluation, endoscopic/radiological appearances, and histology were recruited for the study 
(12). The Montreal classification was used to classify CD location (ileal (L1), colonic (L2), 
ileocolonic (L3), and upper GI (L4)) and disease behavior (non-stricturing, non-penetrating 
(B1), stricturing (B2), and penetrating (B3)) at the time of the diagnosis (13). Date of 
symptom onset and the diagnosis of IBD were recorded. Data on smoking status, alcohol 
consumption, concomitant diseases, history of appendectomy, history of tuberculosis (TB), 
family history of IBD and previous surgeries were collected. OGD and biopsy findings were 
recorded and histology was performed to assess for H. pylori, granuloma, celiac disease and 
microscopic signs characteristic for CD. Patients enrolled in the study did not receive 
eradication therapy at least 6 months prior to inclusion. 
 
OGD evaluated the presence of normal mucosa, macroscopic inflammation, erosions, 
ulcerations, strictures and fistulas. OGD in both center were performed by 2-2 experienced 
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gastroenterologist-endoscopists. Both centres used Olypmus endoscopic equipments: 
Olympus EXERA II series in Szeged and EXERA III series in Hong-Kong. To reduce 
inter-observer variations; both teams agreed on predefined criteria on macroscopic 
definition based on photos and discussion prior to start of study, standardized reporting 
system was used. A shared common database was used to collect clinical and endoscopic 
data from both sites based on a standardized reporting system. This system captures 
macroscopic appearance in the esophagus, stomach and duodenum. Presence of 
macroscopic inflammation, erosions, ulcerations, strictures and fistulas were recorded. Both 
centers used the same standardized proforma which is prospectively collected. The 
endoscopic interpretation was based on agreed and clear definitions prior to study initiation. 
In each patient, two biopsies were taken from each of the corpus, the antrum and the 
proximal part of the duodenum for histological assessment by a single GI pathologist blinded 
to the endoscopic findings. Both pathologists assessed the biopsy samples based on 
well-defined histopathological criteria for the diagnosis of IBD. 
 
The endoscopic criteria for diagnosis of CD contained discontinuous (skip) inflammatory 
lesions, mucosal nodularity or "cobblestoned" mucosa, thickened gastric folds, multiple 
aphthous-like ulcerations and/or linear ulcerations, presence of fistula opening and/or 
stricture. Anatomical criteria of severity are defined as deep ulcerations eroding the muscle 
layer (14). On OGD, a) macroscopic inflammation was defined as mucosal hyperemia or 
erythema, edema or mucosal nodularity; b) aphthous erosion was defined as a superficial 
mucosal break 2-3 mm in diameter and c) ulcer was defined as a linear or serpiginous 
mucosal break ≥3 mm in diameter (15). Histological examination assessed the presence of 
histological features of chronicity and severity of the inflammation, presence of focally active 
gastritis and evaluated the presence of H. pylori, granuloma and celiac disease. For the 
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purpose of this study, upper GI CD was defined according to established criteria, defined as 
macroscopic alteration of the stomach or the duodenum consistent with CD on histology (16). 
Histological features for CD included the presence of non-caseating granulomas, H. 
pylori—negative focally enhanced gastritis, crypt abscesses, or lymphoid aggregates (16).  
 
The control group was also recruited prospectively during the same time period. The control 
group consisted of age- and sex-matched non-IBD participants who underwent OGD for 
different indications including dyspepsia, epigastric pain and regurgitation. 
 
The primary outcome of this study is differences in upper GI CD between Hungarian and 
Chinese CD patients. Secondary outcome included H. pylori positivity in CD in Hungary and 
Hong Kong. 
 
Statistical analyses 
Statistical analysis was performed by an experienced biostatistician. Baseline characteristics, 
endoscopic findings and histological findings between Asian IBD patients and East European 
IBD patients were compared. χ2 –test were used for categorical variables and Mann – 
Whitney U-test were used for continuous variables. P values < 0.05 were considered 
statistically significant. 
 
Ethical statement 
All patients gave informed consent, and the study was approved by the Regional and 
Institutional Human Medical Biological Research Ethics Committee of the University of 
Szeged and by the ethics committee of the New Territory East Cluster with site-specific 
approval from each participating hospital trust. The study was carried out under the 
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declaration of Helsinki. 
 
Results 
Patients with CD 
One hundred and eighty CD patients (100 Hong Kong, China; 80 Szeged, Hungary; 70.6% 
male; mean age: 38.5 years) were included. The clinical demographics of CD subjects are 
summarized in Table 1.  The mean age of CD patients from Hong Kong and Hungary was 41 
and 36 years old (p=0.62), respectively. There were more current smokers amongst CD 
patients in Hungary than in Hong Kong (33.8% vs. 11%; p=0.001). History of appendectomy, 
time of symptom onset and time to diagnosis did not differ between Hungarian and Chinese 
CD patients (Table 1).  
 
There was no difference in disease location between Hungary and Hong Kong. 
Non-stricturing, non-penetrating CD was less common in Chinese than in Hungarian patients 
(41.3% vs. 57%, p=0.036). The proportion of subjects with stricturing or penetrating disease 
did not differ between the two cohorts. There were also no differences in the rates of 
perianal disease, family history of IBD and surgery (Table 1).  
 
At endoscopy, there was no difference in the presence of macroscopic inflammation in the 
stomach between the two cohorts (39.2% vs. 31%; p=0.213). However, gastric erosions were 
identified in a significantly higher proportion of Chinese than Hungarian CD patients (2.5% vs. 
19%; p<0.001). Macroscopic inflammation in the duodenum and duodenal erosions occurred 
more frequently in Hungarian than in Chinese CD patients (13.9% vs. 2%, p≤0.001 and 10.1% 
vs. 1%, p≤0.001) (Table 2).  
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At the time of the study, macroscopic finding of OGD suggested the presence of CD in 24% of 
the Hungarian cases and 4% of the Chinese cases (p≤0.001). Histological inflammation 
suggestive of CD was present in 25.3% of the Hungarian patients and 28% of Chinese patients 
(p=0.658). Combining the macroscopic and microscopic features, CD was proved to be 
present in 16.5% vs. 2% of the Hungarian and Chinese patients (p≤0.001). 
 
Overall 12 patients (6.7%) were re-classified due to OGD. In the Chinese cohort 3 patients 
without upper GI manifestation at diagnosis were classified to have upper GI involvement 
after endoscopy. In addition, 3 patients with initial diagnosis of L4 disease had no evidence of 
upper GI disease on OGD performed during the study thus they were reclassified not having 
upper GI manifestation of CD. These patients were under immunosuppressive therapy and 
remained asymptomatic. In the Hungarian cohort 4 patients without the initial diagnosis of 
L4 disease were classified to have upper GI involvement after endoscopy, while 2 patients 
with upper GI manifestation at diagnosis were reclassified not to suffer from upper GI 
disease.  
 
On histological examination chronic inflammation was the most common finding in both 
groups with predominance of the Hungarian patients (100% vs. 77%, p≤0.001). Focally active 
gastritis was present in 2% of the Chinese and 23.8% of the Hungarian patients (p≤0.001). 
Granulomas were detected in 1% of the Chinese patients and 7.6% of the Hungarian patients 
(p≤0.001). In subjects with macroscopic inflammation, H. pylori positivity was found in 33.3% 
and 7.1% of the Hungarian and the Chinese patients; respectively. Overall H. pylori positivity 
was significantly higher in the Hungarian than in the Chinese CD patients (13.9% vs. 4%, 
p≤0.001). 2.5% of the Hungarian and none of the Chinese CD patients were diagnosed with 
celiac disease (p=0.748). All of the Chinese patients with upper GI manifestation received 
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maintenance azathioprine therapy. In the Hungarian cohort, 40% of the patients with upper 
GI CD were on azathioprine, 50% were treated with 5-aminosalicylate and 35% with 
corticosteroid therapy. 
 
Control patients 
One hundred and eighty nine controls (100 Hong Kong; 89 Hungary; 57.7% male; mean age 
41 years) were recruited in the study. Table 3 shows the basic demographic data of the 
control subjects. The main indication for OGD was epigastric discomfort both in Chinese and 
Hungarian cohorts. Macroscopic inflammation of the esophagus and the stomach was more 
frequently reported in the Chinese than the Hungarian controls (4.5% vs. 16% and 27% vs. 
76%, p≤0.001), although esophageal and gastric erosions occurred more frequently in the 
Hungarian than the Chinese patients (24.7% vs. 0% and 10.1% vs. 3%, p≤0.001). No 
difference was shown in H. pylori positivity between the two control populations (14.6% vs. 
15%, p=0.564). Granuloma did not occur on histological examination, and no difference was 
revealed in the rate of celiac disease. However, none of the patients were diagnosed with 
celiac disease in Chinese patients (2.2% vs. 0%). 
 
CD subjects in Hong Kong had significantly lower H. pylori positivity compared to the 
matched controls (6% vs. 15%; p≤0.001), whereas no difference was found in H. pylori 
positivity between the Hungarian CD and control population (13.9 vs.14.6%; p=0.159) (Table 
2 and 3). 
 
Discussion 
To our knowledge this is the first study that has prospectively examined and compared the 
prevalence of macroscopic and microscopic upper GI manifestations and H. pylori positivity 
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in asymptomatic adult CD patients in two populations of different ethnicities and emerging 
CD incidence. The presence of upper GI CD confirmed by established criteria was 16.5% of 
the Hungarian patients and 2% of the Hong Kong patients; however, the presence of 
histological inflammation suggestive of CD did not differ between the Hungarian and Hong 
Kong CD subjects. When considering endoscopic appearance, gastric erosions occurred more 
frequently in Hong Kong CD patients, while duodenal inflammation and erosions were more 
common in Hungarian vs. Chinese CD patients.  
 
These results can be discussed from at least two different views: on one hand, histological 
criteria of mild upper GI CD are quite accurate and the frequency of upper GI CD is almost 
the same in both areas, however the endoscopic interpretation of macroscopic lesions of 
suspected CD is completely different. On the other hand, the presence of macroscopically 
obvious CD may differ significantly in the two regions. In controls, macroscopic inflammation 
of the upper GI tract was more frequent in Hong Kong patients and erosions occurred more 
frequently in the Hungarian patients. No difference was shown in H. pylori positivity between 
the two control populations. However, H. pylori infection was more commonly detected in 
Hong Kong controls vs. CD patients. 
 
The prevalence of gastroduodenal involvement of CD patients varies between 0.5-13% 
(16-18). In an Italian study upper GI CD was found in approximately 19% of CD subjects being 
similar to our results (19). Macroscopic and histological findings of CD were detected in 
48.7% and 59.7% of CD patients, respectively, and H. pylori was found in in 8.4% CD subjects 
which appeared also to be comparable to the present Hungarian results.   
Focally active gastritis proved to be low in both groups. According to a recently published 
review about the prevalence of upper GI CD and its histopathologic changes, focal gastritis 
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was present in 31% of the patients that is highly similar to that of the Hungarian cohort. The 
review included 20 studies mainly from European countries or the US. Only 2 studies came 
from Japan showing that data from Asia are extremely limited. Moreover, since focal gastritis 
may present in 12% of UC patients and 19% of healthy persons undergoing gastroscopy, it 
cannot distinguish between CD and UC (20, 21). 
 
CD has been reported with an increasing frequency in some Asian countries during the 
recent years. The review by Wang et al. summarized proportions of patients with only small 
intestinal involvement, colonic involvement, or both varying between 28.6-53.8%, 26.9-27%, 
and 19.2-44.4% in Chinese patients compared to the developed countries with a result of 
30%, 15% and 55% in the same locations (22). However, data on upper GI tract involvement 
in Asian CD patients are generally lacking. The study by Leong et al. revealed 19% of the 
patients having involvement proximal to the terminal ileum suggesting a higher frequency of 
upper GI tract CD (8). Notably, in our study we evaluated the involvement of the upper GI 
tract between the esophagus and the duodenum; therefore data of these two studies are 
difficult to be compared. The Hungarian cohort of Lovasz BD et al. revealed upper GI tract 
involvement to be 4.8%, while isolated upper GI tract involvement was only 0.7% (23), which 
is consistent with our findings that none of the patients had isolated upper GI tract 
involvement. During tour study, 6.7% of the patients were re-classified due to OGD. 
 
Upper GI endoscopy is a regularly performed examination in pediatric IBD and significantly 
less frequently used in adults suffering from CD. Although the European Crohn’s and Colitis 
Organization guidelines recommend examination of the location and extent of CD in the 
upper GI tract, irrespective of the findings at ileocolonoscopy, in routine practice, upper 
endoscopy is mainly performed in CD patients with symptoms (14). As confirming the need 
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of routine OGD, routine upper endoscopy has been shown to reveal various rates of 
macroscopic gastroduodenal lesions in 30–75% of CD patients (24, 25). Microscopic 
inflammation is detected in 24-70% of the patients undergoing upper GI endoscopy (26). Our 
results also revealed some macroscopic abnormalities in more than one third of the patients 
with mild chronic inflammation on histology in more than 80% of the patients. The 
occurrence of epitheloid granulomas, being the histological hallmark of CD, varies between 
10-25% (27-29). H. pylori infection on histology occurs in about 10% of CD patients (26). In 
our study, granulomas and H. pylori positivity were more common in Hungarian CD patients. 
Some studies have found a lower prevalence of H. pylori infection in IBD patients vs. healthy 
individuals (30, 31). In the present study, significant difference in H. pylori infection between 
CD patients and controls was only detected in the Chinese population. The meta-analysis by 
Castaño-Rodríguez et al. also reported a stronger negative association between H. pylori 
infection and IBD in Eastern populations than Western populations. Our consistent findings 
may be explained by the difference between the H. pylori strain in Eastern and Western 
populations (31, 32).  
 
The incidence of CD lesions in the upper GI tract is frequently underestimated. Although the 
majority of the macroscopic and microscopic abnormalities were independent from CD, 
macroscopic findings suspicious of CD differed significantly, while histological evaluation of 
CD was highly similar in the two ethnics, endoscopy and histology unanimously disclosed CD 
in 16.5% of the Hungarian and 2% of the Chinese patients of our cohort. This study showed 
different upper GI tract manifestations in the Hungarian and the Hong Kong cohort; however, 
histology suggested CD in significantly higher than expected rate in asymptomatic patients. 
Since the majority of the asymptomatic patients whose initial diagnosis of upper GI tract 
involvement has been altered after the study OGD were under immunosuppressive therapy 
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suggest that adequate immunosuppressive therapy may reverse the upper GI manifestations 
of CD. 
 
The strength of our study is that to our knowledge the first prospective study assessing upper 
GI CD in two populations of emerging disease incidence in parallel during the same time 
period using specific predefined criteria for definition agreed upon prior to start of study. 
Matched controls were also recruited to assess the H. pylori prevalence in two different 
countries of different H. pylori background incidence.  
 
There are also some limitations. There may be inter-observer variation between centers on 
the macroscopic appearance as photos were not routinely captured during study period. 
Nonetheless, photos and strict and validated criteria were used to define these lesions. 
Although central reading for endoscopic mucosal assessment would have provided a more 
relevant comparison between the two regions, centralized assessment of endoscopic 
findings usually relates to studies evaluating experimental drugs or novel scoring systems in 
IBD. Although central reading has been proven to be effective in the assessment of disease 
activity, it has not been tested in the assessment of upper GI CD. Moreover, video acquisition 
is not yet the standard of care in clinical endoscopy suites and may require segmental 
annotation. Moreover, this is a prospective study included data of the real practice collected 
by trained gastroenterologists as well as endoscopists. Endoscopic interpretation was based 
on clear definitions, statistical analysis was correct performed by biostatistician. Our controls 
underwent OGD for certain symptoms so there may be a higher prevalence of finding lesions, 
asymptomatic controls are more ideal to enroll, but ethically challenging. 
 
In conclusion, we have shown that upper GI lesions are less common among asymptomatic 
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Chinese vs. Hungarian CD patients based upon our endoscopic criteria but did not differ if 
considering histological assessment. Gastric erosions are proved to be more common in 
Hong-Kong, duodenal inflammation was more characteristic for Hungarian CD patients. The 
detection of granuloma in Hungary was similar to the literature data, whereas focal gastritis 
was lower than expected in both cohorts.  
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Table 1. The clinical demographics of the Hungarian and Chinese CD patients enrolled in the 
study 
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Table 2. Endoscopic and histological findings of the Hungarian and Chinese CD patients 
enrolled in the study 
 
Table 3. Demographic data of the Hungarian and Chinese control patients enrolled in the 
study 
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